The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has had a positive start to the week and is up over 0.3% to 6,268.3 points in afternoon trade.
Four shares that have failed to follow the market higher today are listed below. Here’s why they started the week in the red:
The G8 Education Ltd (ASX: GEM) share price has tumbled over 15% lower to $2.05 following the release of its half year results. Although G8 Education posted a 7.6% increase in revenue, its underlying earnings before interest and tax fell 21% on the prior corresponding period to $48.1 million. This was due to lower occupancy levels and higher staff costs. G8 Education finished the period with an extremely underwhelming occupancy level of just 70.1%. I would stay well clear of the child care centre operator.
The LiveTiles Ltd (ASX: LVT) share price has fallen almost 4% to 63.5 cents after the software company released its full year results. There were few surprises in the release as much of it had been pre-released as part of its final quarter update. I think LiveTiles is one to watch, though it is a high risk investment.
The Monash IVF Group Ltd (ASX: MVF) share price has plunged 5.5% to $1.21 after the fertility treatment company reported a sharp drop in full year profits. In FY 2018 Monash IVF posted revenue of $150.6 million and net profit after tax of $21.4 million. This was a decline of 2.9% and 27.9%, respectively, on the prior corresponding period. The loss of a key doctor was largely to blame.
The Netcomm Wireless Ltd (ASX: NTC) share price has been smashed and is down 38% to 84 cents. Although the technology equipment company posted a strong full year result with revenue up 69% and EBITDA increasing 5.7 times on the prior corresponding period, management’s guidance appears to have spooked investors. It expects flat underlying EBITDA next year due to lower margins as its sales mix changes shifts to lower margins products and component costs increase. It does appear to expect to return to growth in FY 2020, though.
You might not know this market leader's name, but it's rapidly expanding into a highly profitable niche market here in Australia. Even better, the shares boast a strong, fully franked dividend that should balloon in the years to come. In other words, we're looking at the holy grail of incredible long-term growth potential AND income you can watch accruing in your account in real time!
Simply click here to grab your FREE copy of this up-to-the-minute research report on our #1 dividend share recommendation now.
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Monash IVF Group Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.